HOME >> MEDICINE >> NEWS
Studies provide new evidence on risks associated with Cox-2 inhibitors and NSAIDs

Two new review studies evaluating the safety of the pain-relieving medications selective cyclooxygenase 2 (COX-2) inhibitors and non-steroidal anti-inflammatory drugs (NSAIDs) find increased cardiovascular and kidney risks. The studies and an accompanying editorial were posted online today by JAMA because of the public health implications of the findings. The articles will appear in the October 4 print issue of JAMA.

"It is estimated that more than 30 million people worldwide take nonsteroidal anti-inflammatory drugs (NSAIDs) daily for treatment of pain and inflammation," according to background information provided in one of the articles. Adverse effects of some conventional NSAIDs include toxic gastrointestinal (GI) effects, as well as adverse renal (kidney) effects. "Overall, an estimated 2.5 million individuals in the United States annually experience adverse renal effects caused by use of NSAIDs," the authors write. "With decreased risk of adverse GI effects, a class of drugs that selectively inhibits COX-2 enzyme was introduced for analgesia (pain relief) and the treatment of arthritis." According to the authors, the adverse renal effects of selective COX-2 inhibition are unclear. Evidence is accumulating on the potential class effect of COX-2 inhibitors on cardiovascular risk. Two COX-2 inhibitors have already been withdrawn from the market: rofecoxib (marketed as Vioxx) and valdecoxib (marketed as Bextra).

Jingjing Zhang, M.D., Ph.D., from Brigham and Women's Hospital and Harvard Medical School, Boston, and colleagues evaluated the adverse risks of renal events and arrhythmia (disturbance of the normal heart rhythm) events in patients prescribed COX-2 inhibitors from a systematic review of the medical literature to determine if these negative side-effects involve every drug in this class.

"In this comprehensive meta-analysis of 114 randomized trials of COX-2 inhibitors comprised of 116,094 participants, rofecoxi
'"/>

Contact: Todd Datz
617-432-3952
JAMA and Archives Journals
12-Sep-2006


Page: 1 2 3 4 5

Related medicine news :

1. Studies show antidepressants not linked to birth defects
2. Studies show role of age, gender, race and weight on cancer risk and treatment
3. Studies suggest investigational agent reduces disease activity in MS
4. Studies highlight advances in diagnosis, medical therapy
5. Studies highlight real world use, safety of drug-eluting stents
6. Studies led by Rhode Island Hospital confirm safety and efficacy
7. Studies identify food sources of disease and drug resistance
8. Studies highlight need to monitor heart function in breast cancer patients
9. Studies examine physician disclosure of medical errors
10. Studies indicate medication can be an effective therapy for smoking cessation
11. Studies evaluating health effects of dental amalgam fillings in children confirm safety

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/16/2018)... TORONTO (PRWEB) , ... October 16, 2018 , ... dicentra ... Cannabis Edibles HACCP Certification Program . Canada will become the first G7 country ... 2019, the government of Canada also plans to formally legalize the production and use ...
(Date:10/16/2018)... ... October 16, 2018 , ... AutismOne, the nation’s largest and ... the 4th Annual International HPV Vaccine Education Symposium. , Presenters from countries around ... through Friday, May 24, 2019, with a keynote address from Robert F. Kennedy, ...
(Date:10/13/2018)... ... ... This World Food Day – Tuesday, October 16 – Rise Against Hunger ... by breaking a GUINNESS WORLD RECORDS title with volunteers around the globe. The organization ... international locations together to break the GUINNESS WORLD RECORDS title for the Most people ...
(Date:10/11/2018)... ... 2018 , ... Four weeks before the November 2018 election, ... Department of Homeland Security deputy assistant secretary Paul Rosenzweig in a new online ... , Pointing to the ability of Russian hackers to gain access to 75,000 ...
(Date:10/6/2018)... ... 06, 2018 , ... Jose Rodriguez- Feliz M.D is a ... Beauty, well known for their exclusivity, and luxurious lifestyle publication is privileged to ... addition to the Haute Living network. , Haute Beauty consists of a ...
Breaking Medicine News(10 mins):
(Date:10/11/2018)... ... October 11, 2018 , ... In the last four months it has also ... and allowance of six more in USA, China and Japan from three other patent ... safety and security products. , The patents assigned from QinetiQ include US 7113092, titled ...
(Date:10/7/2018)... , ... October 07, 2018 , ... No one likes to think about an emergency, ... can be disruptive to a family. The local ServPro professional, a trusted leader in the ... shocks of an emergency. , No time is a good time for an emergency, ...
(Date:10/6/2018)... , ... October 06, 2018 , ... The global wellness ... 2015 to $4.2 trillion in 2017, according to an in-depth research report, the ... (GWI). This all-new data on the ten markets that comprise the global wellness economy ...
Breaking Medicine Technology:
Cached News: